Ethocle Reports has published its latest Market Research Report on Rx-OTC Switch Opportunities : Trends in OTC, category analysis, case studies and future opportunities. This report takes an in-depth look at the market for Rx-OTC switches. It considers which categories have the most potential for switching, analyzing both past performance and expected future outcomes, and then examines specific candidates. Browse market data tables and figures.

1. Rx-OTC Switch Opportunities:Trends in OTC, category analysis, case studiesand future opportunities
Ethocle Reportshaspublished its latest MarketResearch Reporton Rx-OTCSwitch Opportunities:
Trends in OTC, category analysis,case studiesand future opportunities.Thisreporttakesan in-depth
lookat the marketforRx-OTCswitches.It considerswhich categorieshavethe mostpotentialfor
switching,analyzing bothpastperformanceand expected futureoutcomes,and then examinesspecific
candidates. Browsemarketdatatablesand figures.
PublishedOn:28-Feb-2015 | Pages:79
Summary
Afteryearsof buoyantgrowth,the pharmaceutical industryisfacinguptoa more challengingtime.With
the growingcost of developingnoveldrugs,combinedwithrisingregulatorypressures,the use of
lifecycle managementisplayinganever-more importantrole inthe increasinglycost-consciouspharma
industry.Thisreportidentifiesactual opportunitiesinOTCswitching.
Click here to find out more about this report?
Key Findings
- The pharmaceutical marketischanging.Since 2007, salesof OTC drugs have outstrippedthose fortheir
prescriptioncounterparts.Whereasonce consumerhealthproductswere seenasa lucrative sideline,
theyare becomingamajorfocus forpharmaceutical companies.Between2008 and 2013, worldwide
OTC growthaveraged6.5% comparedto 4.5% for Rx.
- Creatingnewcategoriescanbe fraughtwith risk.Thiswasshownby the attemptsof GSK to introduce
the weight-losstherapyareawithitsAlli (orlistat60mgcapsules).Afterapromisingstart,salescollapsed
due to concernsoverboth efficacyandsafety.
- Witha large andrapidlyexpandingpopulation,Indonesiaiscatchingthe eye of Westernmultinationals
ina numberof industries.Withinthe pharmaindustry,self-medicationiswell establishedandthese
drugsaccount for 40% of drug spending.
Get Free Sample Report
Click here for Discounts

2. Synopsis
Thisreporttakesan in-depthlookatthe marketforRx-OTCswitches.Itconsiderswhichcategorieshave
the most potential forswitching,analyzingbothpastperformance andexpectedfuture outcomes,and
thenexaminesspecificcandidates.
Reasons To Buy
- Identifyproductsthathave the most Rx-OTCswitchingpotential.
- Analyze the productcategoriesthatare changingthe Rx-OTCenvironment.
- Understandwhysome keyRx-OTCswitcheshave failed.
- Use case studiestoassessthe revenuesgeneratedbysuccessful switches.